InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Henrik Krook, Executive. Officer active across 1 company, notably Egetis Therapeutics AB (publ). Cumulatively, 4 reports have been logged. Activity tracked since 26 November 2025. The latest transaction was disclosed on 11 May 2026 (Purchase). Regulator: FIN-FSA. All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Henrik Krook is a member of the administration of Egetis Therapeutics AB (publ). He is involved in strategic decision-making and oversight of the company's operations.